Paralemmin, a protein predominantly expressed in the nervous system, holds pivotal roles in orchestrating essential cellular processes crucial for neuronal function and synaptic plasticity. As a member of the paralemmin family, it primarily localizes to the plasma membrane and is intricately involved in regulating neuronal morphology, cytoskeletal organization, and synaptic transmission. Paralemmin's functions extend to modulating intracellular signaling cascades and cytoskeletal dynamics, thereby shaping neuronal development and synaptic plasticity. Its interactions with various signaling molecules and cytoskeletal components underscore its significance in regulating neuronal morphology and synaptic function.
Activation of paralemmin involves the initiation of signaling pathways or mechanisms that enhance its regulatory functions within neuronal cells. Mechanistically, activation may entail stimulation of upstream signaling pathways that regulate paralemmin expression or activity, thereby promoting its involvement in cellular processes associated with neuronal morphology and synaptic function. For instance, activation of the Rho GTPase signaling pathway, which governs cytoskeletal dynamics and neuronal morphology, could facilitate paralemmin's interactions with cytoskeletal components, leading to enhanced cytoskeletal organization and neuronal plasticity. Additionally, activation of other signaling pathways implicated in synaptic transmission and neuronal development may also contribute to paralemmin activation, highlighting its multifaceted roles in regulating neuronal function and synaptic plasticity. Overall, understanding the mechanisms of paralemmin activation provides insights into the intricate regulatory networks governing neuronal morphology and synaptic function, offering avenues for further exploration in neurological research.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
Retinoic Acid, involved in neural development, could influence Paralemmin expression by modulating gene expression in neurons. | ||||||
Adenosine 3′,5′-cyclic monophosphate | 60-92-4 | sc-217584 sc-217584A sc-217584B sc-217584C sc-217584D sc-217584E | 100 mg 250 mg 5 g 10 g 25 g 50 g | $116.00 $179.00 $265.00 $369.00 $629.00 $1150.00 | ||
cAMP, a second messenger, may upregulate Paralemmin through its role in synaptic plasticity and neuronal signaling pathways. | ||||||
L-Glutamic Acid | 56-86-0 | sc-394004 sc-394004A | 10 g 100 g | $297.00 $577.00 | ||
Glutamate, the primary excitatory neurotransmitter, might regulate Paralemmin expression through its role in synaptic activity and plasticity. | ||||||
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
Lithium Chloride, known to affect neuronal signaling, could influence Paralemmin expression by modulating signaling pathways like GSK-3β. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin, an activator of adenylate cyclase, may upregulate Paralemmin via increased cAMP levels and subsequent signaling cascades. | ||||||
Valproic Acid | 99-66-1 | sc-213144 | 10 g | $87.00 | 9 | |
Valproic Acid, which affects synaptic plasticity, could indirectly modulate Paralemmin expression through its histone deacetylase inhibitory activity. | ||||||
Fluoxetine hydrochloride | 56296-78-7 | sc-201125 sc-201125A sc-201125B sc-201125C | 50 mg 250 mg 1 g 5 g | $77.00 $213.00 $407.00 $849.00 | 14 | |
Fluoxetine, affecting serotonin uptake, might influence Paralemmin expression as part of its role in neuroplasticity. | ||||||